About
EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced Life Sciences investors with a track record going back 30 years. The firm targets innovative companies focusing on the development of therapeutics, medical devices, diagnostics and healthtech globally. EQT Life Sciences has raised around 3.5 billion euros across 12 private funds and 3 investment strategies. The investment team comes from backgrounds in medicine and science.
Sign up to see Adam Scheid's full profile
Access investment thesis, focus areas, bio, and contact details for Adam Scheid and 22,000+ other VC professionals.
EQT Life Sciences
Amsterdam, NL